Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Survivin promotes a glycolytic switch in CD4+ T cells by suppressing the transcription of PFKFB3 in rheumatoid arthritis. | iScience | 2022 | 36425763 | PubTator, text mining | PubMed |
| ACE2-Independent Alternative Receptors for SARS-CoV-2. | Viruses | 2022 | 36423144 | PubTator, text mining | PubMed |
| Research Progress on Therapeutic Targeting of Cancer-Associated Fibroblasts to Tackle Treatment-Resistant NSCLC. | Pharmaceuticals (Basel) | 2022 | 36422541 | PubTator, text mining | PubMed |
| Genome-Wide RNA Sequencing of Human Trabecular Meshwork Cells Treated with TGF-β1: Relevance to Pseudoexfoliation Glaucoma. | Biomolecules | 2022 | 36421707 | PubTator, text mining | PubMed |
| Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity. | Nat Commun | 2022 | 36418317 | PubTator, text mining | PubMed |
| Glis1 and oxaloacetate in nucleus pulposus stromal cell somatic reprogramming and survival. | Front Mol Biosci | 2022 | 36406265 | PubTator, text mining | PubMed |
| Adipose tissue macrophages: Regulators of adipose tissue immunometabolism during obesity. | Mol Metab | 2022 | 36402403 | PubTator, text mining | PubMed |
| Are targeted therapies or immunotherapies effective in metastatic pancreatic adenocarcinoma? | ESMO Open | 2022 | 36399952 | PubTator, text mining | PubMed |
| Regulatory Networks, Management Approaches, and Emerging Treatments of Nonalcoholic Fatty Liver Disease. | Can J Gastroenterol Hepatol | 2022 | 36397950 | PubTator, text mining | PubMed |
| Identify the immune characteristics and immunotherapy value of CD93 in the pan-cancer based on the public data sets. | Front Immunol | 2022 | 36389798 | PubTator, text mining | PubMed |
| Resolution therapy: Harnessing efferocytic macrophages to trigger the resolution of inflammation. | Front Immunol | 2022 | 36389733 | PubTator, text mining | PubMed |
| The downregulation of LINC00273 inhibits the proliferation, invasion, and migration of ovarian cancer cells in vivo and in vitro. | Ann Transl Med | 2022 | 36388777 | PubTator, text mining | PubMed |
| Single-cell analysis of multiple myelomas refines the molecular features of bortezomib treatment responsiveness. | Exp Mol Med | 2022 | 36380017 | PubTator, text mining | PubMed |
| DNA Polymorphisms in Pregnant Women with Sticky Platelet Syndrome. | J Clin Med | 2022 | 36362759 | PubTator, text mining | PubMed |
| Natural Products for Esophageal Cancer Therapy: From Traditional Medicine to Modern Drug Discovery. | Int J Mol Sci | 2022 | 36362345 | PubTator, text mining | PubMed |
| Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs. | Int J Mol Sci | 2022 | 36362222 | PubTator, text mining | PubMed |
| Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy. | Int J Mol Sci | 2022 | 36361831 | PubTator, text mining | PubMed |
| Integrative Transcriptomic Analysis Identify Potential m6A Pathway-Related Drugs That Inhibit Cancer Cell Proliferation. | Genes (Basel) | 2022 | 36360248 | PubTator, text mining | PubMed |
| Assaying Microglia Functions In Vitro. | Cells | 2022 | 36359810 | PubTator, text mining | PubMed |
| Contemporary Drug Therapy for Renal Cell Carcinoma- Evidence Accumulation and Histological Implications in Treatment Strategy. | Biomedicines | 2022 | 36359359 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=38